Condition: Ophthalmology
The main study purpose is to demonstrate the non-inferiority of T4032 compared to Lumigan® 0.01% in terms of efficacy.
Location(s): Jacksonville - Florida Eye Specialist (Gate)
Condition: Ocular Hypertension, Open Angle Glaucoma
The purpose of this study is to evaluate the efficacy and safety of OCS-01 Ophthalmic Suspension versus placebo (vehicle) in the treatment of inflammation and pain following cataract surgery.
Location(s): Jacksonville - Florida Eye Specialist (Gate)
Condition: Cataract
The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.
Location(s): Jacksonville - Florida Eye Specialist (Gate)
Condition: Ocular Hypertension, Open Angle Glaucoma, Ophthalmology